Luforbec (beclometasone/formoterol) Patient Information

This page is specifically intended to support patients who have been prescribed Luforbec by their healthcare professional.

Luforbec is an inhaler containing the active substances beclometasone and formoterol. The device delivers the active substances to the lungs to help manage the respiratory conditions asthma and chronic obstructive pulmonary disease, otherwise known as COPD.

Beclometasone – belongs to a group of medicines called corticosteroids which have an anti-inflammatory action reducing the swelling and irritation in your lungs.

Formoterol – belongs to a group of medicines called long-acting bronchodilators which relax the muscles in your airways.

Together these two active substances make breathing easier, by providing relief from symptoms such as shortness of breath, chest tightness, wheezing and cough.

If you are allergic or think you are allergic to any of the ingredients of Luforbec,
contact your healthcare professional for advice.

For more information about asthma or COPD speak to your doctor, nurse or pharmacist or visit Asthma UK (https://www.asthma.org.uk/) or the British Lung Foundation (BLF) (https://www.blf.org.uk/).